Atrial fibrilation

http://cardiologysearch.blogspot.in/

Atrial fibrillation
(Classification, Mechanism &

Management)


Introduction…
 AF is characterised by wavelets propagating in different
directions causing disorganized atrial depolarization without
effective atrial contraction

 Electrical activity of atrium can be detected in ECG as small
irregular baseline undulations of variable amplitude &
morphology (f waves) at rate of 350 to 600

 Ventricular response is irregularly irregular, & in untreated
patients with normal AV conduction, is usually between 100 to
160

 WPWsyndrome ventricular rate may be rapid >300 due to
conduction over accessory pathway( short antegrade refractory
periods)


Introduction…
 ventricular rate during AF is altered due to
 Autonomic tone
 Property of AV node
 Effect of drugs on AV conduction


Introduction
 Atrial fibrillation is the most common arrhythmia & the
incidence & prevalence increases with the age

 The incidence
 <0.5% below 50Yrs
 2% in age 60-69
 4.6% in age 70-79
 8.8% in age 80-89

 Men were 1.5 times more likely to develop AF than
women
 Whites were more likely to develop AF than blacks


 Framingham heart study ---cardiac factor
predicting AF
• CHF
• RHD
• HT
• Stroke
• Left atrial enlargement
• Increased LV wall thickness
• Decreased LV fractional shortening


 Relative risk of stroke - 6 fold in non
rheumatic AF
 Relative risk of stroke - 17 fold in
rheumatic AF
 Annual risk of stroke in pt aged 50-
59:1.5%
 Annual risk of stroke in aged 80-89:23.5%

Underlying causes of AF
 CVS
 Tumors
 Rheumatic heart disease  WPW syndrome
 ASD  Systemic
 Cardiac surgery  Alcohol (holiday heart
 Cardiomyopathy syndrome)
 Hypertrophic
 CVA
 Idiopathic
 Infiltrative
 COPD
 Hypertension  Defibrillation
 CAD (Acute & chronic)  Effort
 MVPS  Electrocution
 Non rheumatic mitral or tricuspid
valve disease
 Electrolyte abnormalities
 Pericarditis  Fever
 Tacycardia-bradycardia syndrome  Hypothermia


Underlying causes of AF…

 Pneumonia  Congenital

 Pulmonary embolism  Multiple sclerosis

 Sudden emotion  Muscular dystrophy

 Thyrotoxicosis  Pheochromocytoma

 Trauma  Right atrial cold injections

 Rare  Swallowing

 Acute hypovolemia  Tyramine foods


Classification of Atrial fibrillation

Classification of Atrial
fibrillation
 First detected AF -usually <48hr in
AF during diagnosis
 Paraoxysmal AF - last < 7days
(most<24hrs) self-terminating episodes
 Persistent AF - last >7days requires
electrical or pharmacologic
cardioversion
 Permanent AF - sustained >1yr &
failed cardioversion


Mechanisms
 It was first thought that irregular contractions of the atria are
caused by either single or multiple foci

 In 1924, Garry had suggested reentry to be the mechanism
behind the AF

 In 1960, Moe suggested the “multiple wavelet hypothesis ”

 AF is characterized by fragmentation of a wavefront into
multiple, independent daughter wavelets that move randomly
throughout the atrium, giving rise to new wavelets that collide
with each other & mutually annihilate, or that give rise to new
wavelets in a perpetual activity that resembles Brownian motion

Mechanisms
 Stability of AF is a function of several factors
 Non-uniform distribution of refractory periods

 Specially large tissue area

 Either a relatively brief refractory period or a relatively
slow conduction velocity of the impulse, or both

 Average no. of the wavelets

 Allessie et al, estimated the critical no. of wavelets
to sustain AF was approximately 4 - 6


Mechanisms


Mechanisms
 Trigger factor - self-terminating AF
 Perpetuating factor - AF does not
terminate spontaneously
 Paraoxysmal AF - 95% of Triggering foci
are mapped in pulmonary vein
 Other foci - within SVC ,coronary sinus


Anatomic distribution of focal
trigger in Paraoxysmal AF

Mechanisms
 Waldo et al divided AF into 4 types according atrial
electrogram
• Type – I --- ECG showed discrete complexes of variable
morphology separated by a clear isoelectric baseline

• Type – II --- ECG characterized by discrete atrial
complexes with variable cycle lengths and morphology,
the baseline is not isoelectric

• Type – III --- ECGs were highly fragmented, showing no
discrete complexes or isoelectric intervals

• Type – IV --- Fibrillation was characterized by


Mechanisms
 “ f” waves
 They do not represent total atrial activity but depict only the
larger vectors generated by the multiple wavelets of
depolarization that occur at any given time

 Why ventricular response is irregularly irregular?
 Large no. of atrial impulses that penetrate the AV node, makes
it partially refractory to subsequent impulses

 These effect of non conducted atrial impulses to influence the
response of subsequent atrial impulse is called as “concealed
conduction”


Mechanisms
 Electrical remodelling
 It means long term changes in refractory periods resulting from
prolonged changes in atrial rate
 EPS --- ↓ERP,↓Action potential, ↓ amplitude of AP plateau
 Mechanisms --- Structural , cellular or ion channels It
encompasses diverse structural changes in the myocardium
-interstitial fibrosis

 Alteration in quantity or properties of ion channel proteins in
sarcolemma

 Microscopic changes in cell size , content & extra cellular matrix
leads to irreversible macroscopic changes

Mechanisms http://cardiologysearch.blogspot.in/

 Maladoptations of atrial refractionaries – cause of chronic AF
 Atrial remodelling
 Caused by atrial ischemia & stretch leads to AF due to ↑
automaticity & reentry

 After AF has continued for a long time, atria are not only
electrically remodelled, but atrial contractile function is also
disturbed

 Recovery of atrial transport function may depend upon
duration of AF

 After sinus rhythm is restored, it may take several weeks
before atrial contractility fully returns


Mechanisms
 Modulating factors
 The onset & persistence of AF may be modulated by
autonomic nervous system

 Coumel et al distinguished vagal & adrenergic AF
(distinction is not clear)
 Vagally mediated AF
 Occurs more frequently in men than in women

 Usually younger age group (30 – 50 years)


Mechanisms
 Predominantly occurs in the absence of structural heart disease

 Rarely progresses to permanent AF

 Attacks occur at night, end of the morning

 Neither emotional stress nor exertion trigger the arrhythmia

 Rest, postprandial state, & alcohol are other precipitating
factors

 Mechanism may relate to vagally induced shortening of the
atrial refractory period


Mechanisms
 Adrenergic AF
 More frequently associated with structural heart disease (IHD)

 Occurs during the day time, & it is precipitated by stress,
exercise, tea, coffee or alcohol

 The underlying mechanism is unknown


Hemodynamic effect
 Loss of atrial contraction
 Rapid ventricular rate - ↓duration of
diastole & ventricular filling
 irregular ventricular rhythm - ↓ CO &
coronary blood flow
 Loss of AV synchrony - ↓LVEDP - ↓SV
 AF causes hypotension or pulmonary
oedema in the setting of restrictive
physiology

Antiarrhythmic therapy of atrial fibrillation
 Three antiarrhythmic strategies
 Acute pharmacologic termination
 Prevention of recurrence after cardioversion
 Control of ventricular rate
 Acute conversion of paroxysmal AF
 Pharmacologic cardioversion
 Most effective if initiated within 7 days after onset of AF
 Restoration of sinus rhythm can be achieved in 70% of the
patients
 First choice : Propafenone & flecainide (po & iv), ibutilide,
dofetilide
 Second choice : Amaiodarone (high dose, iv +oral) &
Qunidine (po)

Antiarrhythmic to maintain sinus rhythm in AF

Antiarrhythmic therapy of atrial
fibrillation
 Class IC drugs – Restore sinus rhythm with in a short
period of time ( 1 hour) – conversion rate up to 90% (PAFIT-3)
 Ibutilide
 It acts twice more effectively for conversion of atrial flutter than
atrial fibrillation (63% v 31%)

 Efficacy decreased significantly with AF of >7 days

 Studies, enrolled patients with mild to moderate underlying
disease, so these results may not be generalizable to patients
with markedly depressed LVF

fibrillation
 Dofetilide
 DIAMOND-CHF
 Study of 1518 patients with symptomatic heart failure (EF
<35%)

 Therapy with 1000mic.g was associated with a greater rate of
conversion to sinus rhythm (44% v14%)
 SAFIRE-D
 Study of 325 patients with persistent AF &/or atrial flutter

 Cardioversion rates were 6.1%,9.8% & 29.9% for 125, 250 &
500mic.g bid compared with 1.2% of conversion with placebo


fibrillation
 Amiodarone
 Produce sinus rhythm in 80% within 24hours (late conversion)
 Advantages
 It lowers ventricular rate before conversion (IC drugs increase
the rate)
 Recommended in hemodynamically compromised patients
since it is less negatively inotropic
 Prefered in pts with LVF, LVH, IHD
 IV amiodarone is moderately effective in converting AF
compared with placebo (63% v 44%), with maximum effect at
24hours (74% v 55%) --- 12 meta-analysis
 Higher than usual dose & combination of IV & oral
administration may enhance the cardioversion rate


fibrillation
 Quinidine
 Usually administered in conjunction with B-Blocker

 Cumulative dose of up to 1350mg has shown to cardiovert 50-
77% of patients with recent onset AF
 Sotalol
 It is ineffective in acute conversion

 It is effective for the prevention of AF

 This discrepancy relates to its property to prolong the refractory
period predominantly at lower atrial rates, but not during rapid
AF

fibrillation
 Availability of studies on the efficacy of procainamide &
disopyramide is limited, precluding definite conclusions

 Digitalis, B-Blockers, & CCBs are ineffective for acute conversion
of AF
 DAAF study (Digoxin in acute AF)
 There was no difference in cardioversion rates at 16 hours
between IV digoxin & placebo (51% v 46%)

 Digoxin can facilitate AF due to its cholinergic effects which may
cause a non-uniform reduction in conduction velocity & effective
refractory periods of the atria, and to delay the reversal of
remodelling after restoration of sinus rhythm


Conversion of paroxysmal AF(<3days)

fibrillation
 Prevention of paroxysmal AF
 No need for prophylactic AAD
 After first episode of AF which may self terminate or require
electrical or pharmacologic cardioversion

 Patients with infrequent, self limiting & well tolerated paroxysms
of AF
 Prophylactic AAD are recommended if
 Occurs frequently (1 episode per 3 months)

 Associated with significant symptoms

fibrillation
 Prophylactic AAD are recommended if…
 Worsening of LV function

 In the presence of left atrial enlargement, LVD, underlying
CVS pathology, long duration of AF, advanced age
 B-blockers
 Effective in adrenergic dependent AF (class IA & IC are
ineffective)

 It prevents the recurrence of persistent AF after
cardioversion

fibrillation
 Control of ventricular rate during paroxysmal AF
 Digitalis, B-blockers, CCBs are useful

 Addition of rate controlling drugs is necessary with class IA & IC
drugs (not needed with amiodarone or sotalol)

 Control of ventricular rate in the setting of SSS may be
impossible without implanting pacemaker

 In WPW syndrome complicated by AF – acute rate control &
conversion to SR may be achieved by procainamide or
flecainide

Antithrombotic therapy
 Whether AF is persistent or intermittent ---
Predisposes to stroke
 Non valvular AF
 Most common cardiac disease associated with
cerebral embolism
 The risk of stroke is 5-7 times greater when
compared to control group
 Risk factors that predicts stroke
 Previous stroke or TIA
 Diabetes mellitus
 Systemic hypertension
 Increasing age
 CAD
 CHF

 LV dysfunction & left atrial size > 2.5cm/sq.m --- associated
with thromboembolism

 Age - 60-65, normal echo, no risk factors --- Extremely low
risk for stroke (1% per year)
 Results from 5 large anticoagulation trails
 Annual rate of stroke in control group --- 4.5%

 Annual rate of stroke in warfarin-treated group --- 1.4%
(68% risk reduction)

 Aspirin 325mg/d produced a risk reduction of 44%

 Annual rate of major hemorrhage
 Control group --- 1%

 Aspirin group --- 1%

 Warfarin group --- 1.3%

 No difference was noted in stroke risk, when patients with
paroxysmal (intermittent) AF were compared with chronic AF

 Anticoagulation was 50% more effective than aspirin in
preventing ischemic stroke


 Risk factors for stroke
 Prior stroke or TIA
 Significant valvular heart disease
 Hypertension
 Diabetes mellitus
 Age >65 years
 Left atrial enlargement
 CAD
 Congestive heart failure


 Lone AF
 Age <60years, no risk factors ---No antithrombotic therapy

 Age - 60-75 years (risk-2%per year) ---Aspirin

 Age > 75 years --- Anticoagulation (INR – 2.0)

 Any patients with AF + Risk factors for stroke --- Treated with
warfarin anticoagulation (INR – 2 to 3)

 Patients with contraindication to anticoagulation (or) unreliable
individual (or) no risk factors --- Aspirin

 Risk of embolism after cardioversion
 Risk --- 0 -7%

 Risk is independent of mode of cardioversion
 High risk patients are
 Prior embolism, Mechanical valve prosthesis, Mitral stenosis

 In AF (>2d) --- Warfarin for 3 weeks before cardioversion + 3-4
weeks after reversion to sinus rhythm

 Alternate strategy --- TEE (to exclude LA thrombus) + heparin
before cardioversion + followed by warfarin for 4weeks


 Risk of embolism after cardioversion…
 For emergency cardioversion (TEE cannot be obtained) ---
heparin before cardioversion + followed by warfarin for
4weeks
 Low risk patients
 Age <65 years without risk factor for stroke in nonvalvular AF

 Anticoagulation may not be necessary before cardioversion
but aspirin is indicated

 It is important to emphasize that suggestions must be
individualized for a given patient
 Absolute contraindication for anticoagulation -
ICH,SDH,GI bleed


Non – pharmacologic therapies

 Rhythm control strategies
 Device therapy
 Single site pacing --- High right atrial & septal
 In many patients with SSS, atrial pacmaker allows higher dose
of AAD since sinus node dysfunction is treated

 In patients with paroxysmal AF, there is evidence for intraatrial
conduction delay

 Atrial pacing may decrease the frequency of recurrent AF in
patients who have SSS

 Incidence of AF is lower in patients treated by atrial
pacing than ventricular pacing (prospective studies)
 Multisite pacing --- Biatrial synchronous & Dual site
atrial pacing
 In addition to the high RA lead, another atrial lead is
placed just outside the CS ostium for stability & LA
synchronization

 These pacing cause resynchronization of atrial
depolarisation & helpful in patients with intra atrial
conduction delay

 Usually performed in patients with recurrent,
symptomatic & drug refractory AF

 ECG showed biphasic ‘p’ wave in inferior leads with
abbreviation of ‘P’ wave duration

 Implantable atrial defibrillator

 Automatic atrial defibrillator
• It detect AF by means of implanted RA, CS & RV
leads

• It delivers ‘R’ wave synchronization shock of 6J after
a minimal preceding R-R interval of 500 ms

• Unfortunately this device in its current form is not in
use
 Atrial-ventricular defibrillator/pacemaker
• It has dual chamber algorithm-based arrhythmia
detection

• Pacing & defibrillation therapies for treatment of AF
& atrial tachycardias


 Ablation therapy --- surgical
 His bundle ablation (surgical ligation, mechanical,
cryothermia) + Pace maker implantation

 Corridor surgery
 Creating an isolated strip of muscle to isolate the SA & AV
nodes, thus driving ventricular rate via AV node-His bundle
complex

 But, atrial areas outside of narrow RA corridor continued to
fibrillate with persistent loss of atrial transport function &
persistent risk of thromboembolism

 Maze procedure
 The principle is compartmentalize both atria so that AF
cannot be maintained

 Right & left atrial appendages were resected,
pulmonary vein ostia are isolated, linear RA & LA
lesions are connected to anatomic structures to form
an “electrical maze” --- “Maze 3”

 Appropriately placed atrial incisions not only interrupt
the conduction routes of reentrant circuits, but they
also direct the sinus impulse from SA to AV along a


Indication for maze procedure
 Symptomatic AF
 Refractory to AAD
 Recurrent systemic embolism despite
anticoagulation

Maze procedure
 90% pt cured of AF with operative mortality <1

 <10% requires PPI due to sinus node dysfunction

 Transient fluid retention due to
↓atrial natriuretic
peptide must be treated with diuretics

 The entire atrial myocardium was electrically
activated & atrial transport function is preserved

 Tans catheter ablation therapy
 Linear atrial ablation (Radiofrequency)
 It is employed in LA & RA for substrate compartmentalization

 Trigger ablation (Radiofrequency)
 Focal pulmonary vein
 Pulmonary vein isolation - transseptal puncture followed by
pulmonary venography to define anatomy

 Adverse effect
 Stroke
 Phrenic nerve injury
 Pericardial effusion & tamponade
 Pulmonary vein stenosis


Indication for ablation
 Symptomatic AF
 Refractory to AAD
 Without structural heart disease


 Rate control strategy
 Catheter AV junctional modification (radiofrequency)
 Principle --- Posterior inputs of AV node have shorter ERP, their
ablation slows the ventricular response during AF

 Patient who becomes symptomatic due rapid ventricular
response will benefit

 Currently, AV node modification is usually reserved for patients
who require non-pharmacologic control but are opposed to
pacemaker implantation

 Catheter ablation (DC shock or radiofrequency) +
Pacemaker
 It is performed in patients with unmanageable symptoms
related to rapid ventricular response

 DC current ablation is highly dangerous --- produce electrical
arcing & barotrauma ( cardiac perforation, tamponade, acute
depression of LV, proarrhythmia & sudden death

 Radiofrequency ablation ---avoid complications
 Disadvantages
 Dependence on pacemaker

 Atria will continue to fibrillate --- need long term

 Choice of pace maker type --- determined by the current phase
of AF

 Chronic AF --- VVIR + AV nodal ablation

 Paroxysmal AF ( usually in sinus rhythm between episodes) ---
Dual-chamber pacemaker with mode switching
 Stroke prevention strategy
 Percutaneous LA appendage transcatheter occlusion
(PLAATO)

 Involves insertion of an occlusion device by catheter into the LA
appendage via trans septal puncture

A circular mapping catheter is in the ostium of the left lower
PV and an ablation catheter with a large-tip electrode is
recording a PV potential from the nearby strand.

During radiofrequency ablation near Lasso-8 recording
site, the sharp PVPs are seen in the first two beats but
are absent during the last two beats


Thank you


 Kindly send your suggestions to improve this
site

 Visit us regularly for updates

 Send your articles/ ppt/pdf to publish in this
site .

Introduction

 Paroxysmal AF
 Short lasting < 1 hour
 Long lasting >1; < 48 hours
 AF interspersed with periods of sinus rhythm & usually
terminates spontaneously
 Persistent AF
 Occur between 2days - weeks
 Intervention is needed to restore the sinus rythum
 Chronic or permanent AF
 Persists for months to years
 No spontaneous conversion
 Interventions to restore sinus rythum are either ineffectual or

Mechanisms
 Type – I --- Activation consisted of single, broad wavefronts
propagating without conduction delay & either only short arcs of
conduction block or small areas of slow conduction that did not disrupt
the main course of propagation

 Type – II --- Activation consisted of either the presence of 2 wavelets
or of single wave (with either considerable conduction block or slow
conduction or both)

 Type – III --- Activation was characterized by 3 or more wavelets
combined with areas of slow conduction & multiple arcs of conduction
block

 As the fibrillation changed from type I to III, AFs frequency & irregularity
increased, creating a higher incidence of continuous electrical activity &
reentry


Mechanisms
 Familial AF
• Genetic predisposition – is a hypothesis

• Defect linked to chromosome 10q (21 of 49 members from 3
spanish families presented with AF)

• Missense mutation in the lamin A/C gene (In DCM – associated
with AF)

• Missense mutation Arg663His ( In specific phenotype of HCM –
associated with 47% of AF)


Rate control in atrial fibrillation


Antiarrhythmic therapy of atrial fibrillation


30%

Atrial fibrilation

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (20)

Ähnlich wie Atrial fibrilation

Ähnlich wie Atrial fibrilation (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Atrial fibrilation